Valuation : Bayer AG

Market Cap 48.32B 56.01B 45.51B 41.47B 77.51B 5,291B 78.09B 539B 209B 2,705B 210B 206B 8,885B P/E 2026 *
21.9x
P/E 2027 * 16x
Enterprise Value 78.27B 90.73B 73.73B 67.18B 126B 8,571B 127B 873B 339B 4,382B 341B 333B 14,394B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
99.99%
Yield 2026 *
0.32%
Yield 2027 * 1.08%
1 day+1.13%
1 week+2.64%
Current month+1.47%
1 month+5.60%
3 months+43.40%
6 months+29.89%
Current year+34.45%
1 week 48.45
Extreme 48.45
50.16
1 month 47.22
Extreme 47.22
50.5
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Buy

Director

1,900 0.0002%
18/03/26 Buy

Executive/Senior Manager

13,000 0.0013%
18/03/26 Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+1.13%+2.64%+77.49%-1.74% 56.01B
-0.56%-1.89%+56.39%+106.72% 1,034B
+0.80%+4.25%+55.65%+72.43% 663B
-0.46%+0.70%+22.70%+77.93% 462B
+2.48%-1.90%+32.50%+38.60% 344B
+0.18%+5.42%+27.47%+47.59% 307B
+1.35%+0.05%-0.74%+13.38% 251B
-0.07%+1.37%+56.06%+74.39% 239B
-0.03%+2.18%-17.26%-53.97% 207B
+0.17%+0.47%+32.37%+98.99% 186B
Average +0.54%-0.61%+34.26%+47.43% 374.94B
Weighted average by Cap. +0.31%-0.82%+38.76%+66.83%

Financials

2026 *2027 *
Net sales 45.77B 53.06B 43.12B 39.29B 73.43B 5,012B 73.98B 510B 198B 2,563B 199B 195B 8,418B 47.01B 54.49B 44.28B 40.35B 75.41B 5,147B 75.98B 524B 203B 2,632B 205B 200B 8,645B
Net income 2.14B 2.48B 2.01B 1.83B 3.43B 234B 3.45B 23.83B 9.25B 120B 9.3B 9.1B 393B 2.94B 3.41B 2.77B 2.52B 4.72B 322B 4.75B 32.8B 12.73B 165B 12.8B 12.52B 541B
Net Debt 29.95B 34.72B 28.22B 25.71B 48.06B 3,280B 48.42B 334B 130B 1,677B 130B 128B 5,509B 26.83B 31.1B 25.28B 23.03B 43.05B 2,938B 43.37B 299B 116B 1,502B 117B 114B 4,934B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
03/09/26 49.71 +1.08% 1,162,412
02/09/26 €49.18 +0.61% 1,440,343
01/09/26 €48.88 -0.33% 1,725,190
31/08/26 €49.04 +0.76% 2,098,509
28/08/26 €48.67 +0.39% 1,453,883
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
49.18EUR
Average target price
57.39EUR
Spread / Average Target
+16.69%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock